introduction manifestation peripheral arterial disease pad lower extremity atherosclerotic disease lead represents systemic atherosclerosis involving peripheral artery lead consequence vascular occlusion disability foot ulceration lower extremity amputation markedly decrease quality life increase disability rate financial burden patient many risk factor including cigarette smoking dyslipidemia inflammatory marker lead lead form atherosclerosis likewise increased vascular disease morbidity mortality well rising burden lead expected foreseeable future growing evidence suggests fibrinogen level associated increased lead risk pathogenic role fibrinogen proposed acute thrombotic complication stable form lead extent correlate degree functional impairment research shown fibrinogen strongly predict adverse clinical outcome vascular disease patient according study patient pad cardiovascular disease comorbidities elevated fibrinogen level associated poor clinical outcome study alte found pad outpatient high fibrinogen level associated increased risk ischemic event major bleeding hou observed elevated fibrinogen level baseline day associated poor functional outcome ischemic stroke transient ischemic attack patient revealed traumatic brain injury patient deteriorating fibrinogen value prolonged los intensive care unit los important quality measure ass hospital efficiency performance reducing los could alleviate hospital overcrowding save medical resource reduce healthcare cost notably accumulating evidence patient biochemical indicator associated los xue reported high sensitivity c-reactive protein-albumin protein-prealbumin ratio associated los patient covid-19 neutrophil-to-lymphocyte monocyte-to-lymphocyte ratio correlated los myocarditis patient higher level fibrinogen presentation increased risk prolonged los covid-19 patient age year despite previous study showing association fibrinogen level disease severity prognosis best knowledge study examined potential association fibrinogen level los patient lead therefore studied association fibrinogen level los lead inpatient china method study population january november total inpatient admitted vascular thyroid surgery department china lead lead diagnostic criterion based chinese version lead diagnostic criterion version diagnosis coded according international classification diseases-10th icd-10 discharge criterion lifted target vessel lesion obvious complication patient hospitalization information data recorded electronic hospital information system included demographic data diagnosis medical surgical procedure laboratory measurement physiological measurement trained medical record abstractor extracted hospitalization data using icd-10 code i70.203 lead initially identified inpatient lead excluding patient without fibrinogen data patient missing los data remaining patient finally included study figure show process including excluding participant present study figure flow chart excluding including patient full size image study approved ethic committee first hospital china medical university ethic number patient information anonymized deidentified analysis ethic committee first hospital china medical university waived need informed consent method performed following declaration helsinki exposure outcome exposure variable fibrinogen level measured 8-h fast day admission blood sample fibrinogen testing collected vacuum blood collection tube fibrinogen level measured clotting method using sta-r automated coagulation analyzer stago france outcome variable los refers time interval date admission discharge covariates time admission patient evaluated drinking smoking history lower extremity ischemic symptom lesion site vascular disease history moreover patient subjected routine intravenous sampling fasting day admission including urea total protein activated partial thromboplastin time aptt thrombin time prothrombin calcium triglyceride albumin alb globulin glo phosphorus d-dimer blood sample testing aptt collected vacuum blood collection tube remaining blood sample collected citrate anticoagulant tube measurement biochemical parameter performed clinical laboratory first hospital china medical university shenyang china aforementioned factor taken account confounders study selected potential confounders based association los supplementary table changed estimate fibrinogen level los supplementary table moreover included covariates clinically relevant lead los following covariates finally identified age gender number historical hospitalization surgical history vascular disease history drinking history smoking history insurance type surgical approach lesion site weight loss loss fontaine classification age-adjusted charlson comorbidity index acci urea aptt prothrombin time-international normalized ratio pt-inr calcium alb/glo ratio phosphorus d-dimer statistical analysis descriptive analysis kolmogorov–smirnov test used test normality continuous variable continuous variable nonnormally distributed expressed median interquartile range categorical variable reported number percentage variable selection univariate analysis conducted ass association covariates los screened covariates introducing covariates basic model excluding covariates full model observing change regression coefficient fibrinogen level also calculated variance inflation factor variable generalized linear model ass collinearity multicollinearity observed among variable variance inflation coefficient variable 2.8 regression modeling conducted generalized linear model negative binomial link function explore association fibrinogen level los including crude model controlled confounders model controlled age gender model controlled confounders unordered categorical variable included model using dummy variable address skewness los data employed negative binomial link function within framework generalized linear model negative binomial link function transforms linear combination predictor variable non-negative discrete count value accommodates situation mean variance count data unequal inclusion dispersion parameter allows controlling relationship variance mean also used generalized additive model smoothing spline determine association fibrinogen level los adjusting possible confounders imputed missing baseline confounding data using multiple imputation evaluate whether use indicator variable missing data would lead bias result addition stratified interaction analysis performed based age gender surgical history vascular disease history drinking history smoking history insurance type surgical approach lesion site weight loss fontaine classification also calculated e-value evaluate possibility unmeasured confounding factor fibrinogen level los explored correlation fibrinogen d-dimer acci aptt pt-inr model assessment validation ass accuracy fibrinogen level predicting los day median los receiver operating characteristic roc curve constructed area curve auc compared without fibrinogen level also computed confidence interval auc without fibrinogen level using bootstrap method bootstrap sample calibration plot generated performing bootstrap run ass model calibration decision curve analysis performed ass additional benefit two-tailed -values 0.05 considered statistically significant analysis statistical analysis conducted using stata version 16.0 statacorp college station usa version 3.6.0 foundation statistical computing vienna austria ethic approval consent participate ethic committee first hospital china medical university approved study ethic number patient information anonymized deidentified analysis informed consent needed result baseline characteristic analyzed population comprised male 80.74 female median age year old total patient history vascular disease history surgery table summarizes baseline clinical characteristic participant study table baseline characteristic patient full size table association fibrinogen level los three model conducted analyze association fibrinogen level los shown table unadjusted model showed fibrinogen level associated los 0.75 0.44–1.06 0.001 covariates adjusted coefficient outcome increased remained statistically significant 1.14 0.42–1.86 0.002 positive linear relationship fibrinogen level los also found adjusting confounding factor fig conducting multiple imputation missing baseline data missing completely random result remained robust 0.05 table additionally e-value used verify potential unadjusted confounding value 3.90 table association fibrinogen level length stay performing multiple imputation full size table figure association fibrinogen level length stay full size image different subgroup stratified analysis performed investigate association fibrinogen level los fig interaction analysis difference fibrinogen level los variable interaction 0.05 except age interaction 0.007 figure subgroup analysis association fibrinogen level length stay full size image correlation analysis showed significant relationship fibrinogen d-dimer acci aptt pt-inr 0.05 supplementary fig comparison performance discrimination los day prediction adding fibrinogen level reference model shown supplementary fig reference model included following variable age gender number historical hospitalization surgical history vascular disease history drinking history smoking history insurance type surgical approach lesion site weight loss fontaine classification acci urea aptt pt-inr calcium alb/glo ratio phosphorus -dimer comparison reference model auc 0.800 fibrinogen-added model auc 0.807 prediction accuracy improved value comparison 0.05 bootstrap analysis indicated similar result supplementary table observed predicted probability showed good agreement calibration plot adding fibrinogen level improved agreement slightly analysis decision curve indicated potential value model clinical practice supplementary fig discussion positive linear association found fibrinogen level los patient lead best knowledge study first provide clear evidence association fibrinogen level los lead patient elevation fibrinogen level largely reflects severity underlying lead soluble glycoprotein plasma fibrinogen involved blood clotting response tissue injury vascular injury fibrinogen broken thrombin form fibrin major component blood clot fibrinogen play several function addition role thrombosis making biologically plausible player atherothrombosis fibrinogen stimulate smooth muscle cell proliferate migrate well increase level proinflammatory cytokine additionally affect endothelial integrity permeability vascular wall lure leukocyte blood vessel ligand receptor induces aggregation activates platelet fibrin atherosclerotic lesion responsible formation lipid core binding low-density lipoprotein lipid aforementioned mechanism could account fact elevated fibrinogen level provides useful information estimating likelihood across lead severity likely explains association fibrinogen level prolonged los study correlation observed among fibrinogen d-dimer acci aptt pt-inr indicating factor may synergistic effect severity progression lead marker hypercoagulability d-dimer associated arterial venous thrombosis thrombotic event dyslipidemia increase risk pad triglyceride associated incident pad independently modified form charlson comorbidity index aaci score includes age additional comorbidity factor study indicated age one leading factor underlying development progression symptomatic asymptomatic pad furthermore patient lead often suffer comorbid disease heart failure diabetes coronary heart disease hypertension age comorbidities factor contributing longer los although many condition similar etiological factor lead comorbidities may arise systemic inflammatory response individual fibrinogen inflammatory marker might act indicator aforementioned comorbidities lead patient fibrinogen aptt pt-inr could together reflect coagulation status patient aforementioned finding provide valuable information fibrinogen level may prolong los patient lead despite several important finding study limitation first single-center study finding verified chinese population treatment environment verification group need expanded patient study sample male claudicants finding applicable limited group people second occurrence lead gradual process study considered first fibrinogen level admission unclear whether observed effect transient persistent longitudinal study case conducted future research confirm result third e-value 3.90 suggests unmeasured confounding unlikely fully account finding however could examine unmeasured factor physical activity dietary factor finally study utilized retrospective design future prospective study conducted analyze value panel biochemical hematological inflammatory marker applicable inpatient outpatient setting conclusion summary study result indicate fibrinogen level significantly associated prolonged los lead inpatient setting widely available easily measured indicator patient associated prolonged los fibrinogen level may represent attractive indicator doctor nurse hospital administrator identify lead patient likely prolonged los